Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eastern Chemical is a division of United-Guardian, Inc., specializing in the development and manufacture of specialty chemicals and pharmaceutical products. The company is best known for its proprietary hydrogel technology, Lubrajel, which is widely used in personal care and medical applications as a lubricant and drug delivery vehicle. Its pharmaceutical portfolio includes FDA-approved products such as Renacidin, an irrigation solution for the prevention and dissolution of urinary calculi, and Clorpactin WCS-90, a topical antimicrobial. Eastern Chemical operates out of Hauppauge, New York, providing both proprietary products and contract manufacturing services to the global healthcare industry. The company maintains a strong focus on research and development to expand the applications of its hydrogel platform in various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eastern Chemical.